The Hong Kong United Oncology Centre is currently conducting an international Phase III clinical trial. If you are a patient with locally advanced, unresectable, or metastatic HER2-overexpressing non-squamous non-small cell lung cancer with PD-L1 TPS < 50%, please contact us. We will conduct an initial assessment to determine your eligibility for this clinical trial. Medication and imaging scans are free. However, patients must understand the purpose of the study and any potential risks.
